Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG

BACKGROUND: Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). STUDY DESIGN: Our study is the first to compare four new commercially...

Descripción completa

Detalles Bibliográficos
Autores principales: Krüttgen, Alexander, Cornelissen, Christian G., Dreher, Michael, Hornef, Mathias, Imöhl, Matthias, Kleines, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189838/
https://www.ncbi.nlm.nih.gov/pubmed/32416599
http://dx.doi.org/10.1016/j.jcv.2020.104394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189838/
https://www.ncbi.nlm.nih.gov/pubmed/32416599
http://dx.doi.org/10.1016/j.jcv.2020.104394

Ejemplares similares